ISDS is pleased to present the Revised Guidelines for Syndromic Surveillance Using Inpatient and Ambulatory Clinical Care EHR Data and requests your feedback on these Revised Guidelines during the final 30-day public comment period.
Thank you to everyone who provided feedback on the Draft Guidelines. Over the last month, the Meaningful Use Workgroup revised the Guidelines to better align with stakeholder needs, perspectives, and expectations based on stakeholder comments. You can view a summary of the major changes in the Revised Guidelines document or in the Guidelines FAQ.
ISDS requests your feedback in the coming month during the final, and most important, comment period prior to ISDS' release of recommendations for Meaningful Use. This is your last opportunity to directly shape the recommended guidelines to the ONC, as your input will either support the changes that were made int he Revised Guidelines or emphasize places where further edits are needed.
The comment period will be open from June 5, 2012 - July 3, 2012.
How to provide comments:
1. On-line survey found here: https://www.surveymonkey.com/s/ISDSRevisedGuidelines2012
2. E-mail ISDS Public Health Analyst, Becky Zwickl, MPH at bzwickl@syndromic.org
3. Join an open teleconference call to discuss your comments with your colleagues and MU Workgroup members on Monday, June 18th at 1:00 PM EDT. More information.
4. Schedule a call with Becky Zwickl to provide feedback by contacting her at bzwickl@syndromic.org
You may learn more about the development of the Guidelines for Syndromic Surveillance Using Inpatient and Ambulatory Clinical Care EHR Data and the MU Workgroup members on the ISDS website here: http://www.syndromic.org/meaningfuluse/IAData.
If you have any questions, please contact ISDS Associate Director of Public Health Programs, Charlie Ishikawa, MSPH at meaningfuluse@syndromic.org.
No comments:
Post a Comment